Tekky mate where do you get your numbers from, they're way off. Revenue over $20m (not $10m) and run rate of $28m. Expenses last year was mostly a large one off non cash impairment, the actual operating result improved substantially. Only requires basic maths and financial analysis skills to get this info, you are clearly lacking in this. At least you try to get the numbers (even if it's a complete and embarrassing failure)
- Forums
- ASX - By Stock
- EYE
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-472
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
-0.010(4.55%) |
Mkt cap ! $48.67M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $74.08K | 343.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13355 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 48956 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9355 | 0.220 |
2 | 93130 | 0.215 |
9 | 400896 | 0.210 |
5 | 113536 | 0.205 |
14 | 180879 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 48956 | 3 |
0.205 | 13537 | 1 |
0.215 | 10000 | 1 |
0.225 | 50000 | 1 |
0.230 | 50000 | 1 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online